Literature DB >> 10446063

Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis.

A Bini1, K G Mann, B J Kudryk, F J Schoen.   

Abstract

Advanced atherosclerosis is often associated with dystrophic calcification, which may contribute to plaque rupture and thrombosis. In this work, the localization and association of the noncollagenous bone matrix proteins osteonectin, osteopontin, and osteocalcin with calcification, lipoproteins, thrombus/hemorrhage (T/H), and matrix metalloproteinases (MMPs) in human carotid arteries from endarterectomy samples have been determined. According to the recent American Heart Association classification, 6 of the advanced lesions studied were type V (fibroatheroma) and 16 type VI (complicated). Osteonectin, osteocalcin, and osteopontin were identified by monoclonal antibodies IIIA(3)A(8), G12, and MPIIIB10(1) and antiserum LF-123. Apolipoprotein (apo) AI, B, and E; lipoprotein(a); fibrinogen; fibrin; fragment D/D-dimer; MMP-2 (gelatinase A); and MMP-3 (stromelysin-1) were identified with previously characterized antibodies. Calcium phosphate deposits (von Kossa's stain) were present in 82% of samples (3 type V and 15 type VI). Osteonectin was localized in endothelial cells, SMCs, and macrophages and was associated with calcium deposits in 33% of type V and 88% of type VI lesions. Osteopontin was distributed similarly to osteonectin and was associated with calcium deposits in 50% of type V and 94% of type VI lesions. Osteocalcin was localized in large calcified areas only (in 17% of type V and 38% of type VI lesions). ApoB colocalized with cholesterol crystals and calcium deposits. Lipoprotein(a) was localized in the intima, subintima, and plaque shoulder. Fibrin (T/H) colocalized with bone matrix proteins in 33% of type V and 69% of type VI lesions. MMP-3 was cytoplasmic in most cells and colocalized with calcium and fibrin deposits. MMP-2 was less often associated with calcification. The results of this study show that osteonectin, osteopontin, and osteocalcin colocalized with calcium deposits with apoB, fibrin, and MMP-3 in advanced, symptomatic carotid lesions. These data suggest that the occurrence of T/H might contribute to dystrophic arterial calcification in the progression and complications of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446063     DOI: 10.1161/01.atv.19.8.1852

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

Review 1.  Electron beam tomography as an endpoint for clinical trials of antiatherosclerotic therapy.

Authors:  P Raggi
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

2.  A novel fibre-ensemble level constitutive model for exogenous cross-linked collagenous tissues.

Authors:  Michael S Sacks; Will Zhang; Silvia Wognum
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

Review 3.  Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Authors:  Lauren M Pachman; Adele L Boskey
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

4.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 6.  Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

7.  PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification.

Authors:  F Rutsch; S Vaingankar; K Johnson; I Goldfine; B Maddux; P Schauerte; H Kalhoff; K Sano; W A Boisvert; A Superti-Furga; R Terkeltaub
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

8.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

9.  Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells.

Authors:  Yang Lei; Aditi Sinha; Nasim Nosoudi; Ankit Grover; Naren Vyavahare
Journal:  Exp Cell Res       Date:  2014-01-18       Impact factor: 3.905

10.  Regulation of valvular interstitial cell calcification by components of the extracellular matrix.

Authors:  Karien J Rodriguez; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2009-09-15       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.